LOGIN
ISB with ropivacaine plus perineural or IV buprenorphine, clonidine, & dexamethasone
August 2016
ISB with ropivacaine plus perineural or IV buprenorphine, clonidine, & dexamethasone
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Buprenorphine, Clonidine, Dexamethasone, and Ropivacaine for Interscalene Nerve Blockade: A Prospective, Randomized, Blinded, Ropivacaine Dose-Response Study
Pain Med. 2016 May;17(5):940-60Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
80 patients undergoing total shoulder arthroplasty (TSA) were randomized into one of the four groups for postoperative analgesia. Patients were allocated with either low-dose ropivacaine (0.1%), medium-dose ropivacaine (0.2%), or high-dose ropivacaine (0.375%) interscalene nerve block (ISB) plus perineural clonidine, dexamethasone, buprenorphine, or a control group with ISB with 0.375% ropivacaine...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.